Private company

DURECT CORP

American pharmaceutical preparations company based in Cupertino. Summary from the record

Last updated Oct 19, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersCupertino, United States2
  • Incorporated inDE3
  • Business address10240 Bubb Road, Cupertino, Ca 950143
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation2
  • LEI549300EW9IYW3V3QPJ862
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O UNITED AGENT GROUP INC., 19803 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 28562672

DURECT Corporation (the “Company,” “DURECT,” “we,” “us” and “our”) is a biopharmaceutical company advancing novel and potentially lifesaving investigational therapies derived from our Epigenetic Regulator Program. Larsucosterol, a new chemical entity in clinical development, is the lead candidate in our Epigenetic Regulator Program. An endogenous, orally bioavailable small molecule, larsucosterol has been shown in both in vitro and in vivo studies to play an important regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival. We are developing larsucosterol for alcohol-associated hepatitis (“AH”), a life-threatening acute liver condition with no approved therapeutics and 28-Day and 90-Day historical mortality rates of 20%-26% and 29%-31%, respectively. After completing a Phase 2a trial in which 100% of AH patients treated with larsucosterol survi…4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

-931.2%Operating margin5
-409.8%Net margin5
-21.6%Revenue growth, 20245
-91.2%Return on equity5
-$19.1MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue0¢$78.0K
  • Research and development50¢$10.4M
  • Selling, general and admin50¢$10.5M

Out of $2.0M in revenue.5 The company lost money this year.

Financial statements

Revenue67895$2.0M in 2024−87% since 2018
0$10.0M$20.0M$30.0M$40.0M2018: $15.3M$15.3M20182019: $25.1M$25.1M2019+64%2020: $30.1M$30.1M2020+20%2021: $14.0M$14.0M2021−54%2022: $19.3M$19.3M2022+38%2023: $2.6M$2.6M2023−87%2024: $2.0M$2.0M2024−22%
Operating income67895-$18.9M in 2024−20% since 2018
-$40.0M-$30.0M-$20.0M-$10.0M02018: -$23.6M-$23.6M20182019: -$19.9M-$19.9M2019−16%2020: -$12.6M-$12.6M2020−37%2021: -$34.3M-$34.3M2021+172%2022: -$35.1M-$35.1M2022+2%2023: -$39.7M-$39.7M2023+13%2024: -$18.9M-$18.9M2024−52%
Net income67895-$8.3M in 2024−67% since 2018
-$40.0M-$30.0M-$20.0M-$10.0M02018: -$25.3M-$25.3M20182019: -$20.6M-$20.6M2019−19%2020: -$582.0K-$582.0K2020−97%2021: -$36.3M-$36.3M2021+6131%2022: -$35.3M-$35.3M2022−3%2023: -$27.6M-$27.6M2023−22%2024: -$8.3M-$8.3M2024−70%
Fiscal year2018201920202021202220232024
Revenue$15.3M6$25.1M7$30.1M8$14.0M9$19.3M9$2.6M5$2.0M5
Cost of revenue$1.6M6$1.3M7$1.4M8$2.0M9$1.6M9$268.0K5$78.0K5
Research and development$25.0M6$29.6M7$27.7M8$31.8M9$36.9M9$29.4M5$10.4M5
Selling, general and admin$12.3M6$14.1M7$13.6M8$14.4M9$15.9M9$12.7M5$10.5M5
Operating expenses$48.2M9$54.4M9$42.3M5$20.9M5
Operating income-$23.6M6-$19.9M7-$12.6M8-$34.3M9-$35.1M9-$39.7M5-$18.9M5
Interest$2.6M6$2.5M7$2.2M8$2.1M8$2.4M8
Income tax$09$09$05$05
Net income-$25.3M6-$20.6M7-$582.0K8-$36.3M9-$35.3M9-$27.6M5-$8.3M5
Earnings per share-$0.166-$0.127-$0.038-$1.619-$1.559-$1.055-$0.275
Earnings per share (diluted)-$0.166-$0.127-$0.038-$1.619-$1.559-$1.205-$0.275
Shares (weighted, basic)22.5M shares922.8M shares926.3M shares530.9M shares5
Shares (weighted, diluted)22.5M shares922.8M shares926.5M shares530.9M shares5

Compare DURECT CORP with another company

Leadership

Who has led DURECT CORP, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (21)

Timeline

  1. Feb 6, 1998Founded DURECT CORP is founded2

Filings

224 filings to the SEC since October 2021: 4 annual reports, 12 quarterly reports, 61 major events, 74 insider forms, 13 large holders, 60 other. The latest 20:

  1. Sep 22, 202515-12G EDGAR
  2. Sep 16, 20254/A EDGAR
  3. Sep 12, 2025EFFECT EDGAR
  4. Sep 12, 20254 EDGAR
  5. Sep 12, 20254 EDGAR
  6. Sep 12, 20254 EDGAR
  7. Sep 12, 20254 EDGAR
  8. Sep 12, 20254 EDGAR
  9. Sep 12, 20254 EDGAR
  10. Sep 12, 20254 EDGAR
  11. Sep 12, 20254 EDGAR
  12. Sep 11, 202525-NSE EDGAR
  13. Sep 11, 2025S-8 POS EDGAR
  14. Sep 11, 2025S-8 POS EDGAR
  15. Sep 11, 2025S-8 POS EDGAR
  16. Sep 11, 2025S-8 POS EDGAR
  17. Sep 11, 2025S-8 POS EDGAR
  18. Sep 11, 2025S-8 POS EDGAR
  19. Sep 11, 2025S-8 POS EDGAR
  20. Sep 11, 2025S-8 POS EDGAR

The 224 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

25 open-market trades by officers, directors and large owners since October 2021: 24 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 22, 2025ASEN R SCOTT10% ownerBuy5,917$1.92$11.4KForm 4
Aug 21, 2025ASEN R SCOTT10% ownerBuy116,612$1.90$221.6KForm 4
Aug 20, 2025ASEN R SCOTT10% ownerBuy87,608$1.89$165.6KForm 4
Aug 19, 2022Robertson Judith J.DirectorBuy9,412$0.85$8.0KForm 4
Aug 18, 2022Robertson Judith J.DirectorBuy71,531$0.85$60.8KForm 4
Aug 17, 2022Robertson Judith J.DirectorBuy10,189$0.85$8.6KForm 4
Aug 12, 2022Maderis Gail JDirectorBuy25,204$0.71$17.9KForm 4
Aug 11, 2022Maderis Gail JDirectorBuy24,796$0.70$17.4KForm 4
Aug 10, 2022Maderis Gail JDirectorBuy79,693$0.69$55.0KForm 4
Aug 9, 2022Maderis Gail JDirectorBuy70,307$0.64$45.0KForm 4
May 26, 2022Robertson Judith J.DirectorBuy65,000$0.39$25.4KForm 4
May 24, 2022AZAB MOHAMMADDirectorBuy30,000$0.39$11.7KForm 4
May 18, 2022Farfel Gail MDirectorBuy29,911$0.41$12.3KForm 4
May 17, 2022AZAB MOHAMMADDirectorBuy20,000$0.42$8.4KForm 4
May 16, 2022Farfel Gail MDirectorBuy25,300$0.39$9.9KForm 4
May 16, 2022AZAB MOHAMMADDirectorBuy10,000$0.38$3.8KForm 4
May 13, 2022Farfel Gail MDirectorBuy9,250$0.40$3.7KForm 4
May 12, 2022Farfel Gail MDirectorBuy1,500$0.39$585Form 4
May 11, 2022Farfel Gail MDirectorBuy9,950$0.40$4.0KForm 4
May 10, 2022Farfel Gail MDirectorBuy2,339$0.41$959Form 4

All 25 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42